Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2018 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
Br J Cancer. 2022 Sep;127(5):892-897. doi: 10.1038/s41416-022-01872-w. Epub 2022 Jun 17.
Br J Cancer. 2022.
PMID: 35715630
Free PMC article.
BACKGROUND: To investigate if anti-androgenic medications 5alpha-reductase inhibitors (5-ARIs) decrease the risk of developing oesophageal and gastric tumours, analysed by histological type and anatomical sub-site. ...
BACKGROUND: To investigate if anti-androgenic medications 5alpha-reductase inhibitors (5-ARIs) decrease the risk of developing oesoph …
Cloning of the correct full length cDNA of NF-kappaB-repressing factor.
Jianfeng D, Feng J, Chaoneng J, Zhongzhou Z, Shaohua G, Qihan W, Liu W, Gang Y, Yi X, Mao Y.
Jianfeng D, et al.
Mol Cells. 2003 Dec 31;16(3):397-401.
Mol Cells. 2003.
PMID: 14744032
Free article.
Item in Clipboard
Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy.
Li B, Tao W, Shao-Hua Z, Ze-Rui Q, Fu-Quan J, Fan L, Ze-Fei J.
Li B, et al.
Cancer Biol Ther. 2018 Apr 3;19(4):292-295. doi: 10.1080/15384047.2017.1414761. Epub 2018 Jan 18.
Cancer Biol Ther. 2018.
PMID: 29333945
Free PMC article.
Item in Clipboard
Cite
Cite